Autumn 2004, Vol 11, Issue 3

Featured Article

• Recent Debate over Patent Protection for Medical Related Activities in Japan

Patent Law Recent Developments

• United States
  • Knorr-Bremse v. Dana Corporation revisited by the Federal Circuit
  • Tangential Relationship Found for Added Element Unrelated to Distinguishing the Prior Art
• Europe
  • After-Arising Technology and Extent of U.K. Patents

Message from the Director

Activities

Spring-Summer 2004, Vol 11, Issue 2

Featured Article

• Wanted: The Medical Exemption

Patent Law Recent Developments

• United States
  • En Banc Federal Circuit Will Decide How to Construe Claims
  • Rewriting Dependent Claim into Independent Form with Cancellation of Original Independent Claims Gives Rise to Prosecution History Estoppel
  • Knorr-Bremes v. Dana Corp Decided
  • Clinical Trials Not Covered by §102(b) Experimental Use Negation Doctrine
  • Manufacture of Products Outside US Did Not Violate Permanent Injunction Barring US Activities or US Patent under §271(a).
  • Sow Complicated: Monsanto Co. v. Homan McFarling
• Japan
• Japanese Legislative Updates on Intellectual Property in 2004

Winter 2004, Vol 11, Issue 1

Featured Article:

• Protection Scope for Claims Including Numerical Limitations: Range of Equivalents and Prosecution History Estoppel

Patent Law Recent Developments

• United States
  • Prosecution Laches Applied and No Infringement Found for Lemelson Patents
  • Scope of Surrender: When Claims Are Narrowed for Enablement
  • Is the DMCA Closing the Door on Competition?
  • Written Description Requirement Prevented U of Rochester's Attempt to Capture COX-2 Inhibitor Drugs Sold by Pfizer
  • USPTO Registration Exam for Patent Attorneys and Agents

• Europe
  • Is patent protection for medical treatments available in Europe?

• Japan
  • Two Judgments on Japanese Patent Law Article 35 Amazed Industry All Over the World
  • Quick Review of Systems for Challenging Validity of a Granted Patent before Patent Offices